| Date Filed | Type | Description |
| 06/16/2023 |
4
| Nicholson Garry A (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 10,000 shares
@ $0
Granted 30,000 options to buy
@ $2.83, valued at
$84.9k
|
|
| 09/14/2022 |
4
| Nicholson Garry A (Director) has filed a Form 4 on Day One Biopharmaceuticals, Inc.|
Txns:
| Granted 33,900 options to buy
@ $25.84, valued at
$876k
|
|
| 09/14/2022 |
3
| Nicholson Garry A (Director) has filed a Form 3 on Day One Biopharmaceuticals, Inc. |
| 08/17/2022 |
4
| Nicholson Garry A (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 23,400 options to buy
@ $59.11, valued at
$1.4M
Disposed/sold 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 06/24/2022 |
4
| Nicholson Garry A (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $4.77, valued at
$68k
|
|
| 06/24/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2021 |
4
| Nicholson Garry A (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 14,250 options to buy
@ $8.21, valued at
$117k
|
|
| 06/21/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Nicholson Garry A (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 8,500 options to buy
@ $65.64, valued at
$557.9k
|
|
| 04/19/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/17/2020 |
4
| Nicholson Garry A (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Disposed/sold 25,000 options to buy
@ $59.11, valued at
$1.5M
Granted 23,400 options to buy
@ $59.11, valued at
$1.4M
|
|
| 06/15/2020 |
4
| Nicholson Garry A (Director) has filed a Form 4 on NextCure, Inc.|
Txns:
| Granted 16,083 options to buy
@ $24.13, valued at
$388.1k
Granted 28,500 options to buy
@ $24.13, valued at
$687.7k
|
|
| 06/12/2020 |
4
| Nicholson Garry A (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $17.59, valued at
$351.8k
|
|
| 05/15/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 04/01/2020 |
3
| Nicholson Garry A (Director) has filed a Form 3 on NextCure, Inc. |
| 01/23/2020 |
4
| Nicholson Garry A (Director) has filed a Form 4 on Turning Point Therapeutics, Inc.|
Txns:
| Granted 25,000 options to buy
@ $59.11, valued at
$1.5M
|
|
| 01/23/2020 |
3
| Nicholson Garry A (Director) has filed a Form 3 on Turning Point Therapeutics, Inc. |
| 06/14/2019 |
4
| Nicholson Garry A (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $18.47, valued at
$369.4k
Granted 100,000 options to buy
@ $18.47, valued at
$1.8M
|
|
| 06/12/2019 |
3/A
| Nicholson Garry A (Director) has filed a Form 3/A on FIVE PRIME THERAPEUTICS INC |
| 06/12/2019 |
4
| Nicholson Garry A (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $6.09, valued at
$91.4k
|
|
| 01/22/2019 |
4
| Nicholson Garry A (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Unknown transaction of 1,671 shares
@ $75, valued at
$125.3k
Disposed/sold 4,052 restricted stock units
@ $0
Disposed/sold 25,000 options to buy
@ $60.77, valued at
$1.5M
Disposed/sold 12,000 options to buy
@ $47.27, valued at
$567.2k
Disposed/sold 12,000 options to buy
@ $149.22, valued at
$1.8M
Disposed/sold 7,209 options to buy
@ $46.89, valued at
$338k
|
|
| 09/13/2018 |
4
| Nicholson Garry A (Director) has filed a Form 4 on G1 Therapeutics, Inc.|
Txns:
| Granted 20,000 options to buy
@ $65.75, valued at
$1.3M
|
|
| 09/13/2018 |
3
| Nicholson Garry A (Director) has filed a Form 3 on G1 Therapeutics, Inc. |
| 06/05/2018 |
4
| Nicholson Garry A (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 7,209 options to buy
@ $46.89, valued at
$338k
Granted 4,052 restricted stock units
@ $0 |
|
| 05/14/2018 |
4
| Nicholson Garry A (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 10,000 options to buy
@ $17.27, valued at
$172.7k
|
|
| 06/05/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/12/2017 |
4
| Nicholson Garry A (Director) has filed a Form 4 on FIVE PRIME THERAPEUTICS INC|
Txns:
| Granted 15,000 options to buy
@ $29.8, valued at
$447k
|
|
| 05/12/2017 |
3
| Nicholson Garry A (Director) has filed a Form 3 on FIVE PRIME THERAPEUTICS INC |
| 06/03/2016 |
4
| Nicholson Garry A (Director) has filed a Form 4 on TESARO, Inc.|
Txns:
| Granted 1,269 shares
@ $0
Granted 12,000 options to buy
@ $47.27, valued at
$567.2k
|
|